| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.12 | 0.5 |